10 Top Penny Stocks To Buy For Uner $1 Right Now
Good Penny Stocks To Buy Now? 7 Under $1 To Watch This Week
Cheap Penny Stocks to Buy in September? 3 For Your List
AnPac Bio-Medical Science (ANPC) Stock Surges 66.01%: Details
Best Penny Stocks To Buy Now? 4 To Watch As APE Stock Goes Public
What to Know About Buying Penny Stocks on May 12th
Popular Penny Stocks to Buy in April? 3 to Watch Right Now
Best Penny Stocks To Buy? 5 China Stocks To Watch Right Now
5 Penny Stocks Under $1 To Buy According To Redditors This Week
AnPac Bio Study Shows Strong Correlation between CDA Score and Risk of Cancer and Diseases
AnPac Bio 2021 First Half Revenue Up 128.5% with Non-GAAP Loss Reduced by 18.3%
AnPac Bio Receives NASDAQ Notification Regarding Minimum Market Value of Listed Securities Deficiency
BioMedNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Ownership Increase In Subsidiary Holding
AnPac Bio Increases Ownership Percentage of its Subsidiary AnPai Healthcare from 20% to 60%
AnPac Bio's USA Laboratory Receives Accreditation from the College of American Pathologists
AnPac Bio Successfully Completes Major PreClinical Study, Files with National Medical Products Administration (NMPA) for Registration Testing of Its Multi-Cancer CDA Device
AnPac Bio Taps Life Sciences and Diagnostics Veteran as US CEO
AnPac Bio Announces Appointment of New Independent Director
AnPac Bio Began Generating Contract Medical Device R&D Revenue
AnPac Bio Stock Gains On Robust Growth In Commercial Testing Volume In Q2
AnPac Bio Pre-announces that During First Half 2021, Total Commercial Testing Volume Increased Approximately 110% Over the Same Period 2020 and Q2 Paid Cancer Tests Increased Approximately 270% Over Q1
AnPac Bio-Medical Stock Moves Higher On First Disease Treatment US Patent
Best Biotech Penny Stocks to Buy Next Month? 3 For Your Watchlist
ANPC Stock Price Increases Over 20% Pre-Market: Why It Happened
AnPac Bio's First Disease Treatment Patent Granted, and Its Cancer Treatment Project Secured Multi-Million Dollar Funds
AnPac Bio Reports Strong First Quarter in 2021, with 137.2% Increase in Revenue and Record Number of Commercial Tests Completed
AnPac Bio Shares Jump on Cancer Treatment Technology Related Joint Venture
ANPC Stock Price: Over 6% Increase Pre-Market Explanation
AnPac Bio Launches Novel Cancer Treatment Technology and Product Joint Venture - Utilizing Findings from 10 Years of Early-Stage Cancer Detection Work Involving over 222,200 Sample Database
AnPac Bio-Medical Science Co., Ltd. (ANPC) CEO Dr. Chris Yu on Q4 2020 Results - Earnings Call Transcript
AnPac Bio Announces Filing of Annual Report on Form 20-F for 2020
AnPac Bio to Report Fiscal Year 2020 Financial Results on Friday, April 30, 2021
AnPac Bio Reports Record Q1 for Paid CDA-Based Cancer Testing Volume in 2021, Increasing Approximately 130% Compared to Q1, 2020
ANPC Stock Price Increased 49.22%: Why It Happened
ANPC Stock Price Increases Over 60% Pre-Market: Why It Happened
AnPac Bio Developed and Completed Evaluations of New Generation Cancer Detection Sensor with Improved Performance
AnPac Bio Regains Compliance with Nasdaq Continued Listing Requirement
China's NMPA Approved Starting of Registration Testing of AnPac Bio Class III Medical Device (For Lung Cancer Auxiliary Diagnosis Utility)
AnPac Bio Granted a New US patent on Novel Medical Device for Multi-Cancer Detection
5 Biopharma Stocks Making Big Moves Monday
AnPac Bio Makes Significant Progress in Detecting Pre-cancer Diseases and Recorded Over 20 Types of Pre-cancer Diseases
Anpac Bio Announces Change of Auditor
AnPac Bio-Medical Shares Rally Hard On Record Cancer Testing Volume
Why These 3 Health Care Stocks Are Trading Higher Today
AnPac Bio News: Why ANPC Stock Is Skyrocketing 110% Today
AnPac Bio Sets Record Test Volume in Q3, and Forecasts ~ 100% Revenue Growth in 2020
Anpac Bio Announces Appointment of New Independent Director
AnPac Bio US Completes COVID-19 Antibody Test Verification and Approved to Begin Commercial Testing
AnPac Bio's Investee Company in China Received COVID-19 Nucleic Acid Test Certification and Began Volume Tests and Collaborations with AnPac Bio
Researchers Look for New Ways to Boost Diagnostic Capabilities